Drug · DIN 02460661
GLATECT
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 21, 2017; first marketed August 21, 2017.
- Drug Identification Number (DIN)
- 02460661
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Glatiramer acetate L03AX13
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GLATIRAMER ACETATE | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 17, 2017: NOC 18876New Drug Submission (NDS)